Walgreens June Sales Increase 8.9 Percent
July 03 2014 - 8:00AM
Business Wire
Walgreens (NYSE: WAG) (Nasdaq: WAG) had June sales of $6.28
billion, an increase of 8.9 percent from $5.77 billion for the same
month in fiscal 2013.
Total front-end sales increased 1.8 percent in June compared
with the same month in fiscal 2013, while comparable store
front-end sales increased 1.3 percent. Customer traffic in
comparable stores decreased 2.0 percent while basket size increased
3.3 percent.
Prescriptions filled at comparable stores increased by 7.3
percent in June and increased 4.7 percent on a calendar day-shift
adjusted basis. June 2014 had one additional Monday and one fewer
Saturday compared with June 2013. These calendar shifts positively
impacted prescriptions filled at comparable stores by 2.6
percentage points.
June pharmacy sales increased by 13.4 percent. Comparable store
pharmacy sales increased 11.3 percent and increased by a calendar
day-shift adjusted 8.7 percent. Calendar day shifts positively
impacted pharmacy sales in comparable stores by 2.6 percentage
points. Calendar day-shift adjusted comparable store pharmacy sales
were negatively impacted by 1.4 percentage points due to generic
drug introductions in the last 12 months. Pharmacy sales accounted
for 65.2 percent of total sales for the month.
Sales in comparable stores increased by 7.5 percent in June.
Calendar day shifts positively impacted total comparable sales by
1.7 percentage points. Generic drug introductions in the last 12
months negatively impacted total comparable sales by 0.9 percentage
point.
Calendar 2014 year-to-date sales for the first six months were
$38.13 billion, an increase of 5.9 percent from $36.00 billion in
2013.
Fiscal 2014 year-to-date sales for the first 10 months were
$63.65 billion, an increase of 6.0 percent from $60.04 billion in
fiscal 2013.
Walgreens opened 15 stores during June, including three
relocations, and closed 13. Nearly all of the June store closings
were part of the company’s previously announced efforts to optimize
its asset base by closing a total of 76 drugstores.
On June 30, Walgreens operated 8,319 locations in all 50 states,
the District of Columbia, Puerto Rico, Guam and the U.S. Virgin
Islands. That includes 8,215 drugstores, 117 more than a year ago,
including 70 net stores acquired over the last 12 months. The
company also operates infusion and respiratory services facilities,
specialty pharmacies and mail service facilities. Its Take Care
Health Systems subsidiary manages more than 400 in-store convenient
care clinics.
June Comparable Sales and Prescriptions Filled
Calendar
Cough,
Shift
Generics
Cold, Flu
Actual
Impact
Impact
Impact
Total Comp Sales 7.5% 1.7% - 0.9% 0.0% Comp Front End 1.3% - - -
Comp Rx Sales 11.3% 2.6% - 1.4% 0.1% Comp Rx Scripts 7.3%* 2.6% -
0.2%
* Includes +1.9 percentage points from
patients filling more 90-day prescriptions
Please note: Sales numbers and the adjustments shown in the
table are preliminary, unaudited and subject to revision.
Comparable stores are defined as those drugstore locations open for
at least 12 consecutive months without closure for seven or more
consecutive days and without a major remodel or a natural disaster
in the past 12 months. Acquired operating locations and relocations
are not included as comparable stores for the first 12 months after
the acquisition or relocation.
Cautionary Note Regarding Forward-Looking Statements: Statements
in this release that are not historical are forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words such as
"expect," “likely,” "outlook," “forecast,” "would," "could,"
"should," “can,” “will,” "project," "intend," "plan," "goal,”
“target,” “continue," "sustain," “synergy,” "on track," "believe,"
"seek," "estimate," "anticipate," "may," “possible,” "assume," and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve
risks, assumptions and uncertainties, including, but not limited
to, those described in Item 1A (Risk Factors) of our most recent
Annual Report on Form 10-K, which is incorporated herein by
reference, and in other documents that we file or furnish with the
Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those indicated or anticipated by such forward-looking
statements. Accordingly, you are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date they are made. Except to the extent required by law,
Walgreens does not undertake, and expressly disclaims, any duty or
obligation to update publicly any forward-looking statement after
the date of this release, whether as a result of new information,
future events, changes in assumptions or otherwise.
WalgreensMedia contact:Emily Hartwig, 847-315-3316orInvestor
contacts:Rick Hans, CFA, 847-315-2385Ashish Kohli, CFA,
847-315-3810http://news.walgreens.com@WalgreensNewsfacebook.com/Walgreens
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jun 2024 to Jul 2024
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jul 2023 to Jul 2024